FDA Unveils Cannabis Research Draft Guidance, Sends CBD Enforcement Policy to OMB, and Makes Public CBD Sampling Report to Congress

It has been a busy summer for the cannabis and cannabis-derived products spaces. This month alone, the U.S. Food and Drug Administration (FDA or the Agency): (1) sent to the White House Office of Management and Budget (OMB) for review a “Cannabidiol Enforcement Policy” draft guidance; (2) announced…